Gujarat Themis Biosyn cancels board meeting on June 19
Gujarat Themis Biosyn Limited cancelled its Board meeting scheduled for June 19, 2026, citing unavoidable circumstances. The meeting was originally intended to consider raising funds via equity or debt instruments. The company will inform the exchanges about the revised date in compliance with SEBI regulations.

*this image is generated using AI for illustrative purposes only.
Gujarat Themis Biosyn Limited has cancelled the Board meeting scheduled for June 19, 2026, due to unavoidable circumstances. The company had previously convened the meeting to evaluate a proposal for raising funds through equity shares or various securities. The revised date for the Board meeting will be communicated to the stock exchanges in due course.
The earlier agenda included the consideration of issuing Compulsory Convertible Debentures, Optionally Convertible Debentures, and Non-Convertible Debentures. The proposed fund raising was intended to be conducted through a preferential issue on a private placement basis or any other permissible manner, subject to necessary approvals.
Regulatory Compliance
The intimation regarding the cancellation was submitted to BSE Limited and the National Stock Exchange of India Limited. The company stated that the revised date would be disclosed in compliance with the applicable timelines prescribed under Regulation 29 of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015.
Historical Stock Returns for Gujarat Themis Biosyn
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.44% | +1.09% | -3.82% | +3.93% | +2.60% | +52.14% |
What specific 'unavoidable circumstances' led to the cancellation of the Board meeting?
How might the delay in fund-raising decisions impact Gujarat Themis Biosyn's near-term capital expenditure plans?
Will the company alter the proposed mix of securities (CCDs, OCDs, NCDs) when the meeting is rescheduled?































